Impact of Wearing a Support Garment Following Parietal Gastrectomy

August 4, 2025 updated by: Laurent Biertho, Laval University

Impact of Wearing a Support Garment on Mobility, Functional Capacity, Self-esteem, Quality of Life and Skin Maceration Following Parietal Gastrectomy

Custom-made orthopedic support equipment and abdominal-lumbar support belts offer promising potential for several aspects affecting the health and well-being of people with obesity who choose a surgical weight loss option. However, research is needed to quantitatively document their short and long term effects on a wide range of parameters related to mobility, quality of life, lower back pain and skin maceration following parietal gastrectomy. The objective of this study is to characterize the effect of a support garment in an experimental design where a subgroup of participants will be randomized and followed for the first 12 months after a gastrectomy. The measures will be: physical activity, lower back pain, self-esteem, quality of life, skin maceration and infections. This study will scientifically document the usefulness and effectiveness of support garments throughout the weight loss surgery process.

Study Overview

Status

Terminated

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Quebec City, Quebec, Canada, G1V 4G5
        • Criucpq-Ul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • meeting the NIH criteria for bariatric surgery
  • BMI >= 35 kg/m2

Exclusion Criteria:

  • chronic pulmonary obstructive disease
  • gastric stoma
  • psychiatric disease contraindicated for bariatric surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Sleeve gastrectomy
sleeve gastrectomy
Experimental: Support garment group
Sleeve gastrectomy followed by a period of 12-month with a support garment
sleeve gastrectomy
A custom made support garment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Excess skin
Time Frame: From baseline to 12 month following sleeve gastrectomy
Excess skin measured with the Iglesias scale, scores are from 1 to 5, higher score means a worse excess skin
From baseline to 12 month following sleeve gastrectomy
Skin maceration
Time Frame: From baseline to 12 month following sleeve gastrectomy
maceration evaluated with an in-house questionnaire reported as presence or absence of skin maceration
From baseline to 12 month following sleeve gastrectomy
Skin infection
Time Frame: From baseline to 12 month following sleeve gastrectomy
infection evaluated with an in-house questionnaire reported as presence or absence of skin infection
From baseline to 12 month following sleeve gastrectomy
Impact of excess skin
Time Frame: From baseline to 12 month following sleeve gastrectomy
Sahlgrenska Excess Skin questionnaire assesses excess skin after weight loss for specific body parts and body as a hole. Inconvenience of excess skin is evaluated on a scale from 0 to 10, higher score means higher perception that the excess skin is an inconvenience.
From baseline to 12 month following sleeve gastrectomy
Physical activity
Time Frame: From baseline to 12 month following sleeve gastrectomy
Physical activity evaluated by wearing an activity monitor
From baseline to 12 month following sleeve gastrectomy
Physical activity
Time Frame: From baseline to 12 month following sleeve gastrectomy
Global Physical Activity Questionnaire
From baseline to 12 month following sleeve gastrectomy
Lower back pain
Time Frame: From baseline to 12 month following sleeve gastrectomy
Quebec back pain scale, scores are from 0 to 100, higher score means greater difficulty in carrying out activities due to low back pain
From baseline to 12 month following sleeve gastrectomy
Self esteem
Time Frame: From baseline to 12 month following sleeve gastrectomy
Rosenberg self esteem scale, scores are from 10 to 40, higher score mean a stronger self esteem
From baseline to 12 month following sleeve gastrectomy
Self esteem related to physical appearance
Time Frame: From baseline to 12 month following sleeve gastrectomy
Body Esteem Scale for Adolescent and Adults contains 3 subscales for weight, appearance and attribution. Scores are from 1 to 5, higher score means higher self esteem.
From baseline to 12 month following sleeve gastrectomy
Body image
Time Frame: From baseline to 12 month following sleeve gastrectomy
Gender-specific body-size guide is a pictorial method of assessing the perception of weight status. It consists of 10 standardized images of adults with known BMI values and is a validated body size perception tool. The scale is gender specific and images range from underweight (BMI <18.5) to class III obesity (BMI> = 40) with approximately a 3 point difference in BMI between the figures on the scale.
From baseline to 12 month following sleeve gastrectomy
Body image
Time Frame: From baseline to 12 month following sleeve gastrectomy
body shape questionnaire, scores are from 34 to 204, higher score means worse feeling about the appearance.
From baseline to 12 month following sleeve gastrectomy
Body image
Time Frame: From baseline to 12 month following sleeve gastrectomy
Eating Disorders Examination Questionnaire contains subscales for restraint, eating concern, shape concern and weight concern. Each subscales and global scale scores are form 0 to 6, higher score means worse outcome
From baseline to 12 month following sleeve gastrectomy
Severity of depression symptoms
Time Frame: From baseline to 12 month following sleeve gastrectomy
Beck Depression Inventory II questionnaire, scores are from 0 to 63, higher score means more severe depressive symptoms.
From baseline to 12 month following sleeve gastrectomy
Anxiety
Time Frame: From baseline to 12 month following sleeve gastrectomy
State-Trait Anxiety Inventory contains 2 subscales for usual emotional state and current emotional state. Scores are from 20 to 80, higher scores means higher anxiety state.
From baseline to 12 month following sleeve gastrectomy
Social Physique Anxiety
Time Frame: From baseline to 12 month following sleeve gastrectomy
Social Physique Anxiety Scale, scores are from 12 to 60, higher score means more anxiety
From baseline to 12 month following sleeve gastrectomy
Quality of life
Time Frame: From baseline to 12 month following sleeve gastrectomy
Laval questionnaire contains 6 subscales for symptoms, activity/mobility, personal hygiene/clothing, emotions, social interactions, and sex life. scores are from 1 to 7, higher score means higher quality of life in each domain
From baseline to 12 month following sleeve gastrectomy
marital satisfaction
Time Frame: From baseline to 12 month following sleeve gastrectomy
Dyadic adjustment scale, scores are from 0 to 151, higher score indicates a higher level of marital functioning
From baseline to 12 month following sleeve gastrectomy
social ideals of physical appearance
Time Frame: From baseline to 12 month following sleeve gastrectomy
Sociocultural Attitude Towards Appearance Questionnaire-4 contains 6 subscales (internalization: thinness / low fat mass, internalization: muscular, internalization: general attractiveness, pressures: family, pressures: media, pressures: similar and other significant). Scores are from 1 to 5, higher scores indicating greater internalization and endorsement of societal appearance ideals
From baseline to 12 month following sleeve gastrectomy
gastroesophageal reflux disease
Time Frame: From baseline to 12 month following sleeve gastrectomy
GastroEsophageal Reflux Disease Score, scores are from 0 to 96, higher score indicates worse gastroesophageal reflux symptoms
From baseline to 12 month following sleeve gastrectomy
adherence in wearing the support garment
Time Frame: From baseline to 12 month following sleeve gastrectomy
adherence in wearing the support garment evaluated with an adherence journal. Adherence will be calculated as a percentage from the total number of days the participant wears the garment out of the total for the intervention.
From baseline to 12 month following sleeve gastrectomy
persistence in wearing the support garment
Time Frame: From baseline to 12 month following sleeve gastrectomy
persistence in wearing the support garment will be calculated as a percentage by reporting the number of participants who have stopped wearing the garment compared to those who have used it.
From baseline to 12 month following sleeve gastrectomy
Body composition
Time Frame: From baseline to 12 month following sleeve gastrectomy
body fat composition assessed by impedance
From baseline to 12 month following sleeve gastrectomy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2021

Primary Completion (Actual)

December 1, 2021

Study Completion (Actual)

December 1, 2021

Study Registration Dates

First Submitted

May 28, 2021

First Submitted That Met QC Criteria

June 16, 2021

First Posted (Actual)

June 24, 2021

Study Record Updates

Last Update Posted (Actual)

August 8, 2025

Last Update Submitted That Met QC Criteria

August 4, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Bodynov

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on sleeve gastrectomy

Subscribe